首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Current Oncology

Current Oncology杂志,由Multimed Inc.出版,于1994年创刊,Bimonthly,出版语言English,ISSN:1198-0052,E-ISSN:1718-7729。

投稿咨询
Current Oncology
Current Oncology
Current Oncology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.6
CiteScore
6.1
期刊收录
SCI、SCIE

Current Oncology(中文译名:《当前的肿瘤学》),ISSN:1198-0052,EISSN:1718-7729,是Multimed Inc.出版的国际性学术期刊,创刊于1994年,以Bimonthly形式稳定发行,2026年总发文量约718篇。该刊采用非OA开放访问,学科归属为ONCOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.6,2025年期刊CiteScore为6.1,2025年期刊自引率约2.8%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Current Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约1.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CanadaUSA、CHINA MAINLAND、England、Australia、Belgium、France等为核心发文国家与地区;UNIVERSITY OF TORONTOUNIVERSITY OF OTTAWA、MCMASTER UNIVERSITY、UNIVERSITY OF CALGARY、MCGILL UNIVERSITY、SUNNYBROOK HEALTH SCIENCE CENTER、UNIVERSITY OF BRITISH COLUMBIA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 132 / 333

60.5

学科:ONCOLOGY SCIE Q3 174 / 333

47.9

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 118 / 328

64.2

学科:ONCOLOGY SCIE Q3 174 / 328

47.1


中国学者近期发文

1
A Rare Case of Descending Colon Metastasis Following Radical Nephroureterectomy for Left Ureteral Carcinoma: A Case Report and Literature Revie

Author:Zhang, Huaiwen; Liu, Heyang; Luo, Yousong; Li, Peizhe; Yang, Lianjun; Shi, Jing; Duan, Junyao; Yan, Yongji

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 4, pp. -. DOI: 10.3390/curroncol33040235

2
Acquired Resistance to Afatinib Mediated by EGFR T790M in Lung Adenocarcinoma Patients Harboring EGFR-KDD: A Case Report and Literature Revie

Author:Liu, Qian; Lv, Lu; Pang, Guanchao; Wang, Pingli

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 4, pp. -. DOI: 10.3390/curroncol33040214

3
Lattice Radiation Therapy Plays a Synergistic Role in the Radical Treatment of Bulky Cervical Cancer: A Case Report and Literature Revie

Author:Wang, Feifei; Zhan, Qianru; Dai, Zhitao; Zhang, Huijuan; Peng, Miao; Chen, Zhijian; Jin, Jing; Sheng, Xiugui

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 4, pp. -. DOI: 10.3390/curroncol33040196

4
E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progressio

Author:Yang, Xiaojuan; Zhang, Zhiwei; Lv, Shuangjuan; Zhang, Buzhe; Tao, Xue; Liu, Chang; Zhu, Qing

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 4, pp. -. DOI: 10.3390/curroncol33040186

5
Hepatitis B Virus Infection Is Associated with a Higher Risk of Liver Metastasis in Gastric Cance

Author:Zhu, Songting; Jiang, Mengmeng; Chen, Yanyan; Ding, Yongfeng; Wang, Haiyong; Teng, Lisong

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030179

6
Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinom

Author:Chen, Ping; Wang, Mengchi; Peng, Siyan; Zhu, Honglin; Wang, Yanming; Wan, Zixuan; Yang, Xuan; Yu, Zhixin; Zhou, Yixin

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030173

7
Current Applications and Future Directions of Artificial Intelligence in Prostate Cancer Diagnosis: A Narrative Revie

Author:Zhu, Cong-Yi; Qu, Rui; Dai, Yi; Yang, Luo

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030166

8
Neutrophil Extracellular Traps in Cancer Metastasis: From Mechanistic Understanding to Targeted Therap

Author:Tian, Xiaorui; Na, Jintong; Tan, Xinyi; Dang, Fengqiu; Zhu, Rui; Zhong, Liping; Zhao, Yongxiang

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030156

9
Molecular Mechanisms of Juvenile Nasopharyngeal Angiofibroma: A Narrative Revie

Author:Liu, Xingchen; Hu, Junying; Gan, Weigang; Liu, Feng; Zhong, Bing

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030147

10
Deep Learning-Derived Pathomic Features Predict NCIT Efficacy in Resectable Locally Advanced ESCC: Clinical Utility and Mechanistic Insight

Author:Zhu, Kunrui; Tong, Jie; Duan, Yaqi; Li, Yiming; Feng, Yanqi; Han, Yuelin; Xiao, Xiangtian; Han, Zhuoyan; Xia, Shu

Journal: CURRENT ONCOLOGY. 2026; Vol. 33, Issue 3, pp. -. DOI: 10.3390/curroncol33030136


在线咨询

Current Oncology

国际简称:CURR ONCOL参考译名:当前的肿瘤学

年发文量:718 CiteScore:6.1 是否预警:否 Gold OA文章占比:99.90% 研究类文章占比:71.87%

杂志社联系方式:MULTIMED INC, 66 MARTIN ST, TORONTO, CANADA, ON, L9T 2R2

Current Oncology